PRECIGEN, INC.
For the period ended Sep 30, 2026. Filed Nov 4, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 4, 2026
PGEN$4.52-4.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets as of and
Condensed Consolidated Balance Sheets
| (Amounts in thousands, except share data) | September 30,2026 | December 31,2025 |
|---|---|---|
| Assets | ||
| Current assets | ||
| Cash and cash equivalents | $14,959 | $30,234 |
| Short-term investments | 31,112 | 67,624 |
| Receivables | ||
| Trade, less allowance for credit losses of $0 as of September 30, 2026 and December 31, 2025 | 96,486 | 3,916 |
| Other | 133 | 446 |
| Inventory | 22,915 | 9,581 |
| Prepaid expenses and other | 6,157 | 3,434 |
| Total current assets | 171,762 | 115,235 |
| Long-term investments | 4,909 | 2,511 |
| Property, plant and equipment, net | 13,295 | 13,758 |
| Intangible assets, net | 2,227 | 3,182 |
| Goodwill | 15,232 | 15,232 |
| Right-of-use assets | 4,043 | 4,679 |
| Other assets | 634 | 908 |
| Total assets | $212,102 | $155,505 |
Condensed Consolidated Balance Sheets
| (Amounts in thousands, except share data) | September 30,2026 | December 31,2025 |
|---|---|---|
| Liabilities and Shareholders' Equity | ||
| Current liabilities | ||
| Accounts payable | $7,056 | $11,985 |
| Accrued compensation and benefits | 7,855 | 10,199 |
| Other accrued liabilities | 14,568 | 10,993 |
| Indemnification accruals | — | 2,476 |
| Deferred revenue | 174 | 517 |
| Current portion of lease liabilities | 1,135 | 1,136 |
| Total current liabilities | 30,788 | 37,306 |
| Long-term debt | 94,256 | 93,174 |
| Lease liabilities, net of current portion | 3,216 | 3,980 |
| Other long-term liabilities | 48 | 134 |
| Total liabilities | 128,308 | 134,594 |
| Commitments and contingencies (Note 14) | ||
| Shareholders' equity | ||
| Common stock, no par value, 700,000,000 shares authorized as of September 30, 2026 and December 31, 2025; 358,540,309 shares and 353,910,926 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively. | — | — |
| Additional paid-in capital | 2,377,321 | 2,362,252 |
| Accumulated deficit | (2,293,440) | (2,341,348) |
| Accumulated other comprehensive (loss) income | (87) | 7 |
| Total shareholders' equity | 83,794 | 20,911 |
| Total liabilities and shareholders' equity | $212,102 | $155,505 |
Condensed Consolidated Statements of Operations
| (Amounts in thousands, except share and per share data) · Three Months Ended September 30, · Nine Months Ended September 30, | ||||
|---|---|---|---|---|
| 2026 · 2025 · 2026 · 2025 | ||||
| Revenues | ||||
| Product revenues, net | $72,959 | $162 | $148,049 | $406 |
| Service revenues | 1,189 | 942 | 4,329 | 2,895 |
| Collaboration and licensing revenues | — | 1,818 | — | 1,818 |
| Total revenues | 74,148 | 2,922 | 152,378 | 5,119 |
| Operating Expenses | ||||
| Cost of products and services | 6,508 | 1,035 | 11,872 | 3,227 |
| Research and development | 6,631 | 12,377 | 19,551 | 34,343 |
| Selling, general and administrative | 22,359 | 23,991 | 65,657 | 52,483 |
| Impairment of goodwill | — | — | — | 3,907 |
| Total operating expenses | 35,498 | 37,403 | 97,080 | 93,960 |
| Operating income (loss) | 38,650 | (34,481) | 55,298 | (88,841) |
| Other Income (Expense), Net | ||||
| Change in fair value of warrant liabilities | — | (111,502) | — | (139,523) |
| Interest expense | (2,996) | (902) | (8,857) | (903) |
| Interest income | 323 | 534 | 1,372 | 2,148 |
| Other income (expense), net | (11) | 7 | 295 | (17) |
| Total other expense, net | (2,684) | (111,863) | (7,190) | (138,295) |
| Income (loss) before income taxes | 35,966 | (146,344) | 48,108 | (227,136) |
| Income tax expense | (200) | — | (200) | (3) |
| Net Income (loss) | $35,766 | $(146,344) | $47,908 | $(227,139) |
| Deemed dividend on preferred stock | — | (179,000) | — | (179,000) |
| Net income (loss) attributable to common shareholders | $35,766 | $(325,344) | $47,908 | $(406,139) |
| Net income (loss) per share attributable to common shareholders | ||||
| Net income (loss) per share - basic, attributable to common shareholders | $0.10 | $(1.06) | $0.13 | $(1.36) |
| Net income (loss) per share - diluted, attributable to common shareholders | $0.08 | $(1.06) | $0.12 | $(1.36) |
| Weighted average shares outstanding - basic | 358,249,260 | 307,170,490 | 356,492,444 | 299,210,344 |
| Weighted average shares outstanding - diluted | 421,162,494 | 307,170,490 | 415,432,302 | 299,210,344 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.